Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force - Wikidata - wikimedia - TriplyDB

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force

http://www.wikidata.org/entity/Q27009163

about

Evaluation and Management of the Geriatric Urologic Oncology Patient.The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells.The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.Radical treatment of localised prostate cancer in the elderly.Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer.Managing an Older Adult with Cancer: Considerations for Radiation Oncologists.What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer.

P2860

Q35063815-B04C93F3-1F74-4D37-B251-A3C5D0209FDD Q36546425-640F3ED1-2C2B-45BE-BA6F-7DE38E31B354 Q36550917-608C3C04-9200-43F5-9395-219112CDC1CB Q37116524-B79EFD76-D859-480A-A34F-DDB1CD5C7510 Q38391501-41C73D11-9E8C-48E6-BE10-154CF05811D4 Q39081744-8367AE60-CD14-4B30-B68E-02F43464190C Q42373321-120A14E3-67C3-4471-AA95-D8A5CF8F9D12 Q48128980-F290E39C-AEBD-435C-A157-EC72A4AA770D Q50045189-4759C33D-CEF7-457E-8F94-0D4BD3B249D5 Q52629100-21D3AFD2-8294-4402-A4B2-069A5FDA2851

P2860

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force

http://www.wikidata.org/entity/Q27009163

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Review of current best practic ...... ric Oncology (SIOG) task force

@ast

Review of current best practic ...... ric Oncology (SIOG) task force

@en

Review of current best practic ...... ric Oncology (SIOG) task force

@nl

type

label

Review of current best practic ...... ric Oncology (SIOG) task force

@ast

Review of current best practic ...... ric Oncology (SIOG) task force

@en

Review of current best practic ...... ric Oncology (SIOG) task force

@nl

prefLabel

Review of current best practic ...... ric Oncology (SIOG) task force

@ast

Review of current best practic ...... ric Oncology (SIOG) task force

@en

Review of current best practic ...... ric Oncology (SIOG) task force

@nl

P1433

Q27009163-78E5D645-131D-4A75-A1E1-C33FEA026E2B

P1476

Q27009163-75B91CA9-7F2E-4629-A76E-92FC94700C65

P2093

Q27009163-09139D88-2068-4575-94C7-B0E42C0FCE67

Q27009163-16926B27-7366-4D65-A3F2-1DFD0B665E31

Q27009163-2E6C27D5-3325-45EC-AA46-93D135F24AF4

Q27009163-3903C290-CAAB-4AB0-9B6A-1A84A68FC53A

Q27009163-5043D175-4229-4D96-9277-3B2A6772C6F7

Q27009163-85F07168-9CE7-4FA0-9749-9B5A819D46D6

Q27009163-8C393218-39D5-4FC0-BD68-A8D66B550A9A

Q27009163-915F4CA1-728D-446C-A9BE-428B7B0B3AB0

Q27009163-999211AA-9417-48D3-953B-AAA84FEAC86B

Q27009163-B6074DFC-D97C-4049-9146-4F10DB31C04A

P2860

Q27009163-06DAF609-F571-4E59-97BB-7AC7E5AD8BDF

Q27009163-078CD69D-94B7-4D44-A729-75545B37F06C

Q27009163-088D352C-32F4-41BC-BCC3-557A00095CE7

Q27009163-0FEDCF13-3965-47DD-B4DC-43F17AE2926F

Q27009163-1344BC31-1F4E-4D9B-9FB3-12286FDB1A83

Q27009163-15CC6859-74FD-4C6D-914C-6D5BA70DD09F

Q27009163-1B3E6C10-04C5-4635-909E-256DD3F1C57E

Q27009163-1E0F2FEE-968F-45C9-B612-F2E732F0ADFF

Q27009163-1EC7043F-5728-4673-9ACA-16640661B61A

Q27009163-2284F0CF-269C-4259-9363-83BDF83407D5

P304

Q27009163-3270424A-4D9D-4F4B-8A4E-1BF0AE571557

P31

Q27009163-A52387E1-046B-47ED-9BE0-940F7ABDA387

P3181

Q27009163-32B32EE4-2C12-49A1-83DC-AF03E4EA2A20

P356

Q27009163-A5AE7902-2BD7-4DAD-AE50-7BDE30F1077E

P407

Q27009163-464F1F60-E843-4ED7-BBBC-665A6C0C4A04

P433

Q27009163-DC26F71D-1824-4F58-BA01-4B9A428E8DC8

P478

Q27009163-5B10547A-2BC2-4A59-B9D9-2A10E7CE603C

P577

Q27009163-66A80345-9F03-4FA8-8F4B-90EBD4E4A927

P5875

Q27009163-B93A2F5A-A184-42E1-8193-79DCAFE41C1D

P698

Q27009163-B2F0B48B-BA52-453B-9AFA-86CC82F24C5D

P921

Q27009163-D3D8EAB5-AAD2-415E-B8C5-D0C9B54E4B68

P3181

P356

P1433

Annals of Oncology

P1476

Review of current best practic ...... ric Oncology (SIOG) task force

@en

P2093

A. Markouizou

http://www.w3.org/2001/XMLSchema#string

E. Gore

http://www.w3.org/2001/XMLSchema#string

I. H. Kunkler

http://www.w3.org/2001/XMLSchema#string

J.- L. Lagrange

http://www.w3.org/2001/XMLSchema#string

M. Betz

http://www.w3.org/2001/XMLSchema#string

P. Koper

http://www.w3.org/2001/XMLSchema#string

R. Audisio

http://www.w3.org/2001/XMLSchema#string

R. Pfeffer

http://www.w3.org/2001/XMLSchema#string

S. Hoffe

http://www.w3.org/2001/XMLSchema#string

S. Villa

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients

Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data.

P304

2134-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1322323

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/ANNONC/MDU104

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262047036

http://www.w3.org/2001/XMLSchema#string

P698

24625455

http://www.w3.org/2001/XMLSchema#string

P921